Home  >  Companies  >  Alloy Therapeutics
Alloy Therapeutics
Drug discovery platform and services for antibody, TCR mimic, and oligonucleotide therapeutics

Valuation

$1.00B

2026

Funding

$136.24M

2022

Details
Headquarters
Boston, United States
CEO
Errik Anderson
Website
Milestones
FOUNDING YEAR
2017
Details
Headquarters
Boston, United States
CEO
Errik Anderson
Website
Milestones
FOUNDING YEAR
2017